POTENTIAL AGE MODERATION OF BLUE LIGHT THERAPY ON PTSD SLEEP SYMPTOM SEVERITY
Summary:
This paper investigates the effectiveness of blue light therapy (BLT) in treating sleep disturbances in PTSD patients, and whether age and eye physiology, specifically cataracts, affect the therapy's effectiveness.
Categories
- Post-Traumatic Stress Disorder (PTSD): The paper focuses on the treatment of sleep disturbances in PTSD patients using blue light therapy, and discusses the prevalence and symptoms of PTSD.
- Sleep and insomnia: The paper discusses the impact of PTSD on sleep quality and the potential of blue light therapy to improve sleep disturbances in PTSD patients.
- Aging: The paper examines the potential impact of aging, specifically the development of cataracts, on the effectiveness of blue light therapy in treating sleep disturbances in PTSD patients.
- Phototherapy: The paper explores the use of blue light therapy as a non-pharmacological approach to treating sleep disturbances in PTSD patients.
Author(s)
KH Oxley
Publication Year:
2022
Number of Citations:
0
Related Publications
Post-Traumatic Stress Disorder (PTSD)
- Treatment with morning blue light increases left amygdala volume and sleep duration among individuals with posttraumatic stress disorder
- Morning light treatment for traumatic stress: The role of amygdala reactivity study protocol
- Impact of blue light exposition to alertness of shift workers, patients with sleep deprivation, Alzheimer's disease, or post-traumatic stress disorder
- Trastorno de estrés post-traumático y tratamiento con EMDR desde la neuropsicología
Sleep and insomnia
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
- Functional and morphological differences among intrinsically photosensitive retinal ganglion cells
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead